Literature DB >> 1559982

The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi.

A E Eakin1, A A Mills, G Harth, J H McKerrow, C S Craik.   

Abstract

The complete sequence of the gene encoding the major cysteine protease from Trypanosoma cruzi is reported. The amino acid sequence predicted from the gene sequence aligns well with members of the papain family of cysteine proteases, suggesting the name cruzain. The sequence is most closely related to the cysteine protease of Trypanosoma brucei (59.3%) and the murine cathepsin L (42.2%). At least six copies of the gene are present in the genome and are organized in a tandem array of copies which are identical in all restriction endonuclease sites tested. The gene appears to be expressed in all developmental stages of T. cruzi with mRNA levels approximately 2-fold higher in the intracellular amastigote form. A copy of the T. cruzi gene was expressed in bacteria as an inactive, insoluble fusion polypeptide to approximately 5% of the total cell protein. The fusion protein was readily purified, solubilized in urea, and successfully refolded to produce a polyprotein which processed autocatalytically to yield approximately 1 mg of active protease per 3 g of wet cell paste. The processed form of the recombinant protease has an NH2-terminal sequence identical to that of the mature form of the protease purified from T. cruzi (Murta, A. C. M., Persechini, P. M., Souto-Padrón, T., de Souza, W., Guimaraes, J. A., and Scharfstein, J. (1990) Mol. Biochem. Parasitol. 43, 27-38; Cazzulo, J. J., Couso, R., Raimondi, A., Wernstedt, C., and Hellman, U. (1989) Mol. Biochem. Parasitol. 33, 33-42). This suggests that the recombinant protease possesses the requisite specificity and activity to correctly process the proform of the protease in vitro. Kinetic assays with peptide substrates demonstrate that the substrate specificity and kinetic parameters for the recombinant protease are consistent with those of the endogenous protease. The proteolytic activity of the recombinant protease is enhanced by dithiothreitol, inhibited by leupeptin, N alpha-p-tosyl-L-lysine chloromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64) but is unaffected by phenylmethylsulfonyl fluoride, pepstatin, and 1,10-phenanthroline. More specifically, the recombinant enzyme was inhibited by benzyloxycarbonyl-Phe-Arg-fluoromethyl ketone, which inhibits replication and differentiation of T. cruzi within mammalian cells in culture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559982

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

Authors:  J M Santana; P Grellier; J Schrével; A R Teixeira
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.

Authors:  Daniel J Rigden; Vladimir V Mosolov; Michael Y Galperin
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

Review 3.  Effects of dibucaine on the endocytic/exocytic pathways in Trypanosoma cruzi.

Authors:  Thaïs Souto-Padrón; Ana Paula Lima; Rachel de Oliveira Ribeiro
Journal:  Parasitol Res       Date:  2006-04-13       Impact factor: 2.289

4.  Fibronectin-degrading activity of Trypanosoma cruzi cysteine proteinase plays a role in host cell invasion.

Authors:  Fernando Yukio Maeda; Cristian Cortez; Mario Augusto Izidoro; Luiz Juliano; Nobuko Yoshida
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 5.  Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.

Authors:  Chunfang Ling; Junyan Zhang; Deqiu Lin; Ailin Tao
Journal:  World J Microbiol Biotechnol       Date:  2015-03-20       Impact factor: 3.312

6.  Identification of Structure-Stabilizing Interactions in Enzymes: A Novel Mechanism to Impact Enzyme Activity.

Authors:  Marisol Serrano; Veronica Gonzalez; Supriyo Ray; Maria D Chavez; Mahesh Narayan
Journal:  Cell Biochem Biophys       Date:  2017-07-29       Impact factor: 2.194

7.  Reversible cysteine protease inhibitors show promise for a Chagas disease cure.

Authors:  Momar Ndao; Christian Beaulieu; W Cameron Black; Elise Isabel; Fabio Vasquez-Camargo; Milli Nath-Chowdhury; Frédéric Massé; Christophe Mellon; Nathalie Methot; Deborah A Nicoll-Griffith
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

8.  A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes.

Authors:  Isabela M Aparicio; Julio Scharfstein; Ana Paula C A Lima
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues.

Authors:  G L Wijffels; M Panaccio; L Salvatore; L Wilson; I D Walker; T W Spithill
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

10.  In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

Authors:  Yen Ting Chen; Linda S Brinen; Iain D Kerr; Elizabeth Hansell; Patricia S Doyle; James H McKerrow; William R Roush
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.